21 Key patents such as US 10,278,923 (expiring 2034) and US 11,833,248 (expiring 2039) ensure that even after the core semaglutide compound patent expires in 2031, the oral market remains protected for nearly another decade
Storage requirements for GLP-1 medications vary by product and depend on whether the product is a multi-dose pen (used multiple times) or a single-dose pen (used once and discarded)
When switching is not possible Patients with type 1 diabetes cannot switch from insulin to a GLP-1 medication
However, in ferroptosis-resistant OC cells, erastin paradoxically enhances metastatic potential by influencing the tumor microenvironment
Of these 14 semaglutide tablet -treated patients, 7 patients (0.2% of the total semaglutide tablet-treated study population) developed antibodies that cross-reacted with native GLP-1
Vomiting occurs in 8-17% of cases, again dose-dependent